Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist.
暂无分享,去创建一个
T. Moody | M. Birrer | I. Gozes | J. Reubi | M. Fridkin | Y. Gozes | S. Jakowlew | T. Hida | H. Zia
暂无分享,去创建一个
T. Moody | M. Birrer | I. Gozes | J. Reubi | M. Fridkin | Y. Gozes | S. Jakowlew | T. Hida | H. Zia